Menú
  • Home
  • USR Metropolitana Nord

USR Metropolitana Nord

RESPONSABLE
avatar_investigadors.jpg
Pere Torán Monserrat
ptoran.bnm.ics@gencat.cat
USR Metropolitana Nord - foto

Publications

The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort study.

Alvarez-Sierra D, Martínez-Gallo M, Sánchez-Montalvá A, Fernández-Sanmartín M, Colobran R, Espinosa-Pereiro J, Poyatos-Canton E, Zurera-Egea C, Sánchez-Pla A, Violan C, Parra R, Alzayat H, Vivancos A, Morandeira-Rego F, Urban-Vargas B, Martínez-Cáceres E, Hernández-González M, Bas-Minguet J, Katsikis PD, Teniente-Serra A and Pujol-Borrell R
CLINICAL IMMUNOLOGY. 2025 Mar 1; . doi:10.1016/j.clim.2025.110429; PMID:39842683

See more:
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.

Arteaga I, Chacón C, Martínez-Escudé A, Rojano IR, Diez-Fadrique G, Carmona-Cervelló M and Torán-Monserrat P
Diagnostics. 2025 Jan 27; . doi:10.3390/diagnostics15030299; PMID:39941229

See more:
Development of Attention-based Prediction Models for All-cause Mortality, Home Care Need, and Nursing Home Admission in Ageing Adults in Spain Using Longitudinal Electronic Health Record Data

L. CARRASCO-RIBELLES, M. CABRERA-BEAN, S. KHALID, A. ROSO-LLORACH and C. VIOLAN
JOURNAL OF MEDICAL SYSTEMS. 2025 Jan 25; . doi:10.1007/s10916-024-02138-z; PMID:39862306

See more:
Correction: Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study).

Aznar-Lou I, Zabaleta-Del-Olmo E, Casajuana-Closas M, Sánchez-Viñas A, Parody-Rúa E, Bolíbar B, Iracheta-Todó M, Bulilete O, López-Jiménez T, Pombo-Ramos H, Martín Miguel MV, Magallón-Botaya R, Maderuelo-Fernández JÁ, Motrico E, Bellón J, Martí-Lluch R, Rubio-Valera M and Serrano-Blanco A
International Journal of Behavioral Nutrition and Physical Activity. 2024 Dec 9; . doi:10.1186/s12966-024-01674-8; PMID:39654047

See more:
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.

Torán-Monserrat P, Lamonja-Vicente N, Costa-Garrido A, Carrasco-Ribelles LA, Quirant B, Boigues M, Molina X, Chacón C, Dacosta-Aguayo R, Arméstar F, Martínez Cáceres EM, Prado JG and Violán C
JMIR Public Health and Surveillance. 2024 Nov 22; . doi:10.2196/56926; PMID:39648969

See more: